USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke TYMPANOGRAFT wurde als Wortmarke am 07.12.2004 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".
| Markenform | Wortmarke |
| Aktenzeichen | 78528677 |
| Anmeldedatum | 07. Dezember 2004 |
| Veröffentlichungsdatum | 08. November 2005 |
Markeninhaber
86 Morris Avenue
07901 Summit
US
07901 Summit
US
Markenvertreter
Waren und Dienstleistungen
1
biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific, laboratory and medical research; configurations, namely decellularized, square, round, with or without cells; biochemical catalysts for use in medical research; biological preparations for medical purposes, namely for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; proteins for industrial and human consumption, namely animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; chemical preparations used to protect crops in the agricultural and horticultural field
5
biological tissue intended for subsequent implantation namely, blood, stem cells, umbilical cords and placentas for medical and clinical use; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriological culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system
42
development of new technology for others in the field of genomics, biotechnology; discovery, development and commercialization of therapies designed to treat cancer and immunological diseases through regulation of cellular, genomic and proteomic targets; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods; agrochemical product development for others
44
collection and preservation of human blood, umbilical cord blood, stem cells, umbilical cords and placentas; and providing medical and pharmaceutical information services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1378528677